Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086017575> ?p ?o ?g. }
- W2086017575 endingPage "11546" @default.
- W2086017575 startingPage "11537" @default.
- W2086017575 abstract "Inasmuch as the neurohormone melatonin is synthetically derived from serotonin (5-HT), a close interrelationship between both has long been suspected. The present study reveals a hitherto unrecognized cross-talk mediated via physical association of melatonin MT2 and 5-HT2C receptors into functional heteromers. This is of particular interest in light of the “synergistic” melatonin agonist/5-HT2C antagonist profile of the novel antidepressant agomelatine. A suite of co-immunoprecipitation, bioluminescence resonance energy transfer, and pharmacological techniques was exploited to demonstrate formation of functional MT2 and 5-HT2C receptor heteromers both in transfected cells and in human cortex and hippocampus. MT2/5-HT2C heteromers amplified the 5-HT-mediated Gq/phospholipase C response and triggered melatonin-induced unidirectional transactivation of the 5-HT2C protomer of MT2/5-HT2C heteromers. Pharmacological studies revealed distinct functional properties for agomelatine, which shows “biased signaling.” These observations demonstrate the existence of functionally unique MT2/5-HT2C heteromers and suggest that the antidepressant agomelatine has a distinctive profile at these sites potentially involved in its therapeutic effects on major depression and generalized anxiety disorder. Finally, MT2/5-HT2C heteromers provide a new strategy for the discovery of novel agents for the treatment of psychiatric disorders.Background: There is cross-talk between serotonin and melatonin hormones.Results: There is evidence for unidirectional transactivation and a heteromer-specific signaling profile for formation of functional melatonin MT2 and serotonin 5-HT2C receptor heteromers.Conclusion: A new potential target of the antidepressant agomelatine is identified.Significance: The importance of binding of multitarget drugs to GPCR heteromers in psychiatric disorders is demonstrated. Inasmuch as the neurohormone melatonin is synthetically derived from serotonin (5-HT), a close interrelationship between both has long been suspected. The present study reveals a hitherto unrecognized cross-talk mediated via physical association of melatonin MT2 and 5-HT2C receptors into functional heteromers. This is of particular interest in light of the “synergistic” melatonin agonist/5-HT2C antagonist profile of the novel antidepressant agomelatine. A suite of co-immunoprecipitation, bioluminescence resonance energy transfer, and pharmacological techniques was exploited to demonstrate formation of functional MT2 and 5-HT2C receptor heteromers both in transfected cells and in human cortex and hippocampus. MT2/5-HT2C heteromers amplified the 5-HT-mediated Gq/phospholipase C response and triggered melatonin-induced unidirectional transactivation of the 5-HT2C protomer of MT2/5-HT2C heteromers. Pharmacological studies revealed distinct functional properties for agomelatine, which shows “biased signaling.” These observations demonstrate the existence of functionally unique MT2/5-HT2C heteromers and suggest that the antidepressant agomelatine has a distinctive profile at these sites potentially involved in its therapeutic effects on major depression and generalized anxiety disorder. Finally, MT2/5-HT2C heteromers provide a new strategy for the discovery of novel agents for the treatment of psychiatric disorders. Background: There is cross-talk between serotonin and melatonin hormones. Results: There is evidence for unidirectional transactivation and a heteromer-specific signaling profile for formation of functional melatonin MT2 and serotonin 5-HT2C receptor heteromers. Conclusion: A new potential target of the antidepressant agomelatine is identified. Significance: The importance of binding of multitarget drugs to GPCR heteromers in psychiatric disorders is demonstrated." @default.
- W2086017575 created "2016-06-24" @default.
- W2086017575 creator A5036118383 @default.
- W2086017575 creator A5036953090 @default.
- W2086017575 creator A5041494494 @default.
- W2086017575 creator A5049449969 @default.
- W2086017575 creator A5054899121 @default.
- W2086017575 creator A5056373892 @default.
- W2086017575 creator A5064018437 @default.
- W2086017575 creator A5065139379 @default.
- W2086017575 creator A5070542395 @default.
- W2086017575 creator A5070828234 @default.
- W2086017575 creator A5071215322 @default.
- W2086017575 creator A5083058332 @default.
- W2086017575 creator A5083750721 @default.
- W2086017575 creator A5087022175 @default.
- W2086017575 date "2015-05-01" @default.
- W2086017575 modified "2023-10-15" @default.
- W2086017575 title "Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers" @default.
- W2086017575 cites W2001818691 @default.
- W2086017575 cites W2003227337 @default.
- W2086017575 cites W2009442121 @default.
- W2086017575 cites W2016556735 @default.
- W2086017575 cites W2021553547 @default.
- W2086017575 cites W2021706058 @default.
- W2086017575 cites W2024942419 @default.
- W2086017575 cites W2027999012 @default.
- W2086017575 cites W2029021490 @default.
- W2086017575 cites W2033244960 @default.
- W2086017575 cites W2037024495 @default.
- W2086017575 cites W2041138404 @default.
- W2086017575 cites W2043368216 @default.
- W2086017575 cites W2045208242 @default.
- W2086017575 cites W2059477617 @default.
- W2086017575 cites W2060673080 @default.
- W2086017575 cites W2064264742 @default.
- W2086017575 cites W2066199795 @default.
- W2086017575 cites W2068275172 @default.
- W2086017575 cites W2071793091 @default.
- W2086017575 cites W2073570537 @default.
- W2086017575 cites W2089441939 @default.
- W2086017575 cites W2098876955 @default.
- W2086017575 cites W2101832118 @default.
- W2086017575 cites W2103431948 @default.
- W2086017575 cites W2103919506 @default.
- W2086017575 cites W2106497761 @default.
- W2086017575 cites W2117528472 @default.
- W2086017575 cites W2123329342 @default.
- W2086017575 cites W2141239982 @default.
- W2086017575 cites W2151314016 @default.
- W2086017575 doi "https://doi.org/10.1074/jbc.m114.559542" @default.
- W2086017575 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4416857" @default.
- W2086017575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25770211" @default.
- W2086017575 hasPublicationYear "2015" @default.
- W2086017575 type Work @default.
- W2086017575 sameAs 2086017575 @default.
- W2086017575 citedByCount "90" @default.
- W2086017575 countsByYear W20860175752015 @default.
- W2086017575 countsByYear W20860175752016 @default.
- W2086017575 countsByYear W20860175752017 @default.
- W2086017575 countsByYear W20860175752018 @default.
- W2086017575 countsByYear W20860175752019 @default.
- W2086017575 countsByYear W20860175752020 @default.
- W2086017575 countsByYear W20860175752021 @default.
- W2086017575 countsByYear W20860175752022 @default.
- W2086017575 countsByYear W20860175752023 @default.
- W2086017575 crossrefType "journal-article" @default.
- W2086017575 hasAuthorship W2086017575A5036118383 @default.
- W2086017575 hasAuthorship W2086017575A5036953090 @default.
- W2086017575 hasAuthorship W2086017575A5041494494 @default.
- W2086017575 hasAuthorship W2086017575A5049449969 @default.
- W2086017575 hasAuthorship W2086017575A5054899121 @default.
- W2086017575 hasAuthorship W2086017575A5056373892 @default.
- W2086017575 hasAuthorship W2086017575A5064018437 @default.
- W2086017575 hasAuthorship W2086017575A5065139379 @default.
- W2086017575 hasAuthorship W2086017575A5070542395 @default.
- W2086017575 hasAuthorship W2086017575A5070828234 @default.
- W2086017575 hasAuthorship W2086017575A5071215322 @default.
- W2086017575 hasAuthorship W2086017575A5083058332 @default.
- W2086017575 hasAuthorship W2086017575A5083750721 @default.
- W2086017575 hasAuthorship W2086017575A5087022175 @default.
- W2086017575 hasBestOaLocation W20860175751 @default.
- W2086017575 hasConcept C104317684 @default.
- W2086017575 hasConcept C126322002 @default.
- W2086017575 hasConcept C1292079 @default.
- W2086017575 hasConcept C135285700 @default.
- W2086017575 hasConcept C169760540 @default.
- W2086017575 hasConcept C170493617 @default.
- W2086017575 hasConcept C185592680 @default.
- W2086017575 hasConcept C2775864247 @default.
- W2086017575 hasConcept C2778182776 @default.
- W2086017575 hasConcept C2778938600 @default.
- W2086017575 hasConcept C2779177272 @default.
- W2086017575 hasConcept C2780798758 @default.
- W2086017575 hasConcept C2781161787 @default.
- W2086017575 hasConcept C53910766 @default.
- W2086017575 hasConcept C55493867 @default.
- W2086017575 hasConcept C71924100 @default.